Ultrapotent COVID-19 vaccine candidate designed via computer: Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models

An ultrapotent nanoparticle candidate vaccine against COVID-19 has been developed with structure-based vaccine design techniques invented at UW Medicine. It is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 Spike protein's receptor-binding domain in a highly immunogenic array. The molecular structure of the vaccine roughly mimics that of a virus, which may account for its enhanced ability to provoke an immune response.